跳到正文

Monopar Therapeutics(MNPR)内部人交易:高管与董事近期交易

过去 18 个月,共有 13 位内部人为 Monopar Therapeutics(MNPR)报告了 93 笔 Form 4 交易(最近一笔 2026-11-04)。

日期内部人职务类型股数市值
2026-11-04Tsuchimoto Kim R董事买入1,199$35,970
2026-11-04Anderson Raymond董事买入1,402$42,058
2026-11-04Tsuchimoto Kim R董事卖出1,199$84,050
2026-11-04Anderson Raymond董事买入1,740$52,200
2026-11-04Tsuchimoto Kim R董事买入856$25,680
2026-11-04Anderson Raymond董事卖出840$55,574
2026-11-04Tsuchimoto Kim R董事买入2,035$28,490
2026-11-04Anderson Raymond董事卖出600$40,236
2026-11-04Tsuchimoto Kim R董事卖出1,295$91,621
2026-11-04Anderson Raymond董事卖出200$13,736
2026-11-04Tsuchimoto Kim R董事卖出996$71,065
2026-11-04Anderson Raymond董事卖出1,502$105,200
2026-11-04Tsuchimoto Kim R董事卖出600$43,326
2026-10-20Robinson ChandlerChief Executive Officer卖出597$55,276
2026-10-05STARR CHRISTOPHER M董事卖出4,631$361,635
2026-10-05STARR CHRISTOPHER M董事买入8,400$42
2026-10-05STARR CHRISTOPHER M董事卖出2,970$234,095
2026-10-05STARR CHRISTOPHER M董事卖出799$63,656
2026-10-02Robinson ChandlerChief Executive Officer买入9,801$0
2026-10-02Cittadine AndrewChief Operating Officer买入4,384$0
2026-10-02Vu Quan AnhChief Financial Officer买入614$0
2026-10-02Robinson ChandlerChief Executive Officer卖出4,344$346,086
2026-10-02Cittadine AndrewChief Operating Officer卖出1,944$154,878
2026-10-02Vu Quan AnhChief Financial Officer卖出180$14,341
2026-09-28Robinson ChandlerChief Executive Officer买入14,056$421,680

来源:SEC Form 4 申报文件 · 截至 2026-11-04